Virus News and Research

Latest Virus News and Research

New computational approach may predict how individuals are likely to respond to vaccines

In an advance that sheds light on why certain vaccines may influence people differently, a new computational approach developed at the University of Michigan may predict how individual patients are likely to respond.

2 Sep 2021

Impact of COVID-19 vaccination pausing on uptake

A recent study looks at the implications of pausing vaccinations against COVID-19 due to blood clotting concerns.

2 Sep 2021

New walk-through coronavirus testing facility opened in Bangor

A new walk-through coronavirus testing facility has opened for those with symptoms to book appointments at Beach Street Car Park West (LL57 1AT) in Bangor, as part of the UK Government's UK-wide drive to continue to improve the accessibility of coronavirus testing for local communities.

2 Sep 2021

Voters in tight recall race sound off on California Gov. Newsom’s covid leadership

Gov. Gavin Newsom's first term in office has been defined by his response to the covid-19 pandemic, which has claimed the lives of more than 65,400 Californians.

2 Sep 2021

Should pregnant women be vaccinated against COVID-19?

A recent study examines whether COVID-19 risks in pregnant women justify the administration of COVID-19 vaccines to pregnant individuals.

2 Sep 2021

Climate and COVID-19 spread

A new study examines whether the number of infections and the mortality due to the virus is related to the temperature, rainfall, sunlight, and ultraviolet index (UVI).

2 Sep 2021

Risk of COVID-19 transmission from animals to older adults

A new study in the journal GeroScience deals with this aspect of the disease, especially with respect to preventing higher death rates in older adults.

2 Sep 2021

International taskforce recommends neurocognitive tests to harmonize assessment of long COVID

An international taskforce created by a UNSW Science psychology researcher has recommended a set of neurocognitive and mental health questionnaires to harmonize the assessment of patients with long COVID.

2 Sep 2021

Study identifies how immune sensors launch a multi-faceted innate immune response to infections

St. Jude Children's Research Hospital immunologists have identified how immune sensors in infected cells organize and launch a multi-faceted innate immune response to infections with live viruses and bacteria. The discovery appears today in Nature.

2 Sep 2021

Newly discovered cell type makes survivors of sepsis more vulnerable to infections

Sepsis is the leading cause of death in Brazil's intensive care units (ICUs). Among patients who progress to the severe form of the disease, 40% die, and the survivors often suffer from cardiovascular and neurological complications, as well as a significant decline in immunity lasting for years after they are discharged from hospital.

2 Sep 2021

Immune cells present in tumors from head and neck cancer patients, study reports

A new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the major targets of immune checkpoint inhibitors are present in tumors from head and neck cancer patients.

2 Sep 2021

Regional differences in prevalence of SARS-CoV-2 antibodies in children

A population-based study assesses seroprevalence in a representative sample of children from regions with high and low community transmission.

2 Sep 2021

An assessment of post-vaccination immune response to SARS-CoV-2 Delta in elderly and health care workers

A new cohort study comparing immune responses among vaccinated elderly persons and healthcare workers has been conducted.

2 Sep 2021

COVID-19 associated with increased risk of kidney damage, end-stage kidney diseases

A study by researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System shows that people who have had COVID-19, including those with mild cases, are at an increased risk of developing kidney damage as well as chronic and end-stage kidney diseases.

1 Sep 2021

Tutoring revolution takes place as pupils return to school

Schools will have greater flexibility to offer high-quality, 15-hour tutoring courses that meet the needs of their pupils, in a major expansion of the National Tutoring Programme backed by £1 billion.

1 Sep 2021

Experts show waning effectiveness of COVID-19 vaccines over time

In a letter to The New England Journal of Medicine, publishing online September 1, 2021, an interdisciplinary team of physicians and public health experts at University of California San Diego measured the effectiveness of COVID-19 mRNA vaccines among health workers at UC San Diego Health, most notably during the emergence of the highly transmissible delta virus variant and coincident with the end of the state's mask mandate, allowing fully vaccinated persons to forgo face coverings in most places.

1 Sep 2021

Early implementation of COVID-19 shutdowns saved thousands of lives in St. Louis area

In March 2020, not long after the first cases of COVID-19 were reported locally, health officials in the city of St. Louis and St. Louis County issued emergency public health orders intended to reduce interactions between people and slow the transmission of the novel respiratory virus.

1 Sep 2021

Saliva test screenings contribute to low transmission of COVID-19 in schools for children with IDD

Studies have determined that in-school transmission of the virus that causes COVID-19 is rare when masking, social distancing and other safety protocols are followed.

1 Sep 2021

Nanoparticle-based disinfectant could be a powerful weapon against pathogenic viruses

University of Central Florida researchers have developed a nanoparticle-based disinfectant that can continuously kill viruses on a surface for up to seven days – a discovery that could be a powerful weapon against COVID-19 and other emerging pathogenic viruses.

1 Sep 2021

Study shows bacille Calmette-Guérin vaccine can protect mice against lethal SARS-CoV-2 challenge

A recent US study, currently available on bioRxiv* preprint server, implies that vaccination with bacille Calmette-Guérin (BCG) can limit the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by targeting innate immune pathways and could thus be used as a platform for pinpointing early immunologic events affecting the outcome of coronavirus disease (COVID-19).

1 Sep 2021

Virus News and Research

Latest Virus News and Research

New computational approach may predict how individuals are likely to respond to vaccines

Impact of COVID-19 vaccination pausing on uptake

New walk-through coronavirus testing facility opened in Bangor

Voters in tight recall race sound off on California Gov. Newsom’s covid leadership

Should pregnant women be vaccinated against COVID-19?

Climate and COVID-19 spread

Risk of COVID-19 transmission from animals to older adults

International taskforce recommends neurocognitive tests to harmonize assessment of long COVID

Study identifies how immune sensors launch a multi-faceted innate immune response to infections

Newly discovered cell type makes survivors of sepsis more vulnerable to infections

Immune cells present in tumors from head and neck cancer patients, study reports

Regional differences in prevalence of SARS-CoV-2 antibodies in children

An assessment of post-vaccination immune response to SARS-CoV-2 Delta in elderly and health care workers

COVID-19 associated with increased risk of kidney damage, end-stage kidney diseases

Tutoring revolution takes place as pupils return to school

Experts show waning effectiveness of COVID-19 vaccines over time

Early implementation of COVID-19 shutdowns saved thousands of lives in St. Louis area

Saliva test screenings contribute to low transmission of COVID-19 in schools for children with IDD

Nanoparticle-based disinfectant could be a powerful weapon against pathogenic viruses

Study shows bacille Calmette-Guérin vaccine can protect mice against lethal SARS-CoV-2 challenge

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in